SCHEMBL6982624

SCHEMBL6982624

Cc1ccc2cc(NS(=O)(=O)c3ccc(CBr)cc3)ccc2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
LMNA P02545 5/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
CDC7 O00311 1/20 0.47
EEF2K O00418 1/20 0.47
PLK4 O00444 1/20 0.47
AURKA O14965 1/20 0.47
DYRK3 O43781 1/20 0.47
RPS6KA5 O75582 1/20 0.47
PRKD3 O94806 1/20 0.47
MAP4K4 O95819 1/20 0.47
PIM1 P11309 1/20 0.47
PHKG2 P15735 1/20 0.47
CDK2 P24941 1/20 0.47
AKT1 P31749 1/20 0.47
AKT2 P31751 1/20 0.47
MAPK8 P45983 1/20 0.47
MAPKAPK2 P49137 1/20 0.47
GSK3A P49840 1/20 0.47
GSK3B P49841 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5335572 0.86 MAPT (0.57) ALDH1A1LMNASMN1; SMN2CDC7EEF2K
SCHEMBL6984638 0.83 SMN1; SMN2 (0.63) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL9676236 0.75 NPC1 (0.51) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL29518266 0.74 CYP1A2 (0.57) LMNANPC1RAB9AKDM4E
SCHEMBL1206321 0.74 CYP1A2 (0.57) LMNANPC1RAB9AKDM4E
SCHEMBL28842217 0.74 NPC1 (0.54) ALDH1A1LMNASMN1; SMN2CDC7EEF2K
SCHEMBL5763131 0.72 PKM (0.43) ALDH1A1KDM4EMAPTPKMGAA
SCHEMBL5348053 0.70 ALPL (0.58) ALDH1A1LMNASMN1; SMN2CDK2HTT
SCHEMBL13713001 0.70 CYP1A2 (0.55) ALDH1A1LMNANPC1RAB9AKDM4E
SCHEMBL5337489 0.70 ATM (0.55) ALDH1A1LMNASMN1; SMN2CDC7EEF2K

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed